BGI's Counterpunch Against Illumina Draws Mixed Reaction
A California federal judge overseeing Illumina's patent infringement suit against China-based BGI Genomics over DNA sequencing technology gave a mixed response to BGI's counterclaims at a hearing Wednesday, saying BGI's induced...To view the full article, register now.
Already a subscriber? Click here to view full article